Close Menu

nanochannels

In 2017, Bionano had $9.5 million in revenues and a net loss of 23.4 million, or $7.66 per share.

With its Direct Labeling and Staining (DLS) chemistry, currently available to early-access users, Bionano is pushing forward with more contiguous genome maps.

BioNano Genomics has launched its nanochannel-based single-molecule DNA mapping platform in Europe and plans to extend the technology to human-size genomes later this year, enabling researchers to discover new structural variants, separate haplotypes, and obtain better genome ass

BioNanomatrix has changed its name to BioNano Genomics, the company said this week.
Through the name change, the firm wants to communicate "its position as a solution provider for genomics researchers."

The Philadelphia-based Princeton University spinout plans to use $830,000 in new supplemental grant funding from the National Human Genome Research Institute to prepare for beta-testing of its NanoAnalyzer next year.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.